{"product_id":"global-cancer-immunotherapy-market-2023-2027","title":"Global Cancer Immunotherapy Market 2023-2027","description":"\u003cp\u003eGlobal Cancer Immunotherapy Market 2023-2027\u003cbr\u003e\nThe cancer immunotherapy market is forecasted to grow by USD 38.57 bn during 2022-2027, accelerating at a CAGR of 7.42% during the forecast period. The report on the cancer immunotherapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.\u003c\/p\u003e\n\n\u003cp\u003eThe report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of cancer, growing awareness among consumers regarding cancer immunotherapy, and strong R and D pipeline of monoclonal antibodies.\u003c\/p\u003e\n\n\u003cp\u003eTechnavio's cancer immunotherapy market is segmented as below:\u003c\/p\u003e\n\n\u003cp\u003eBy TypeMonoclonal antibodiesCheck point inhibitors and immunomodulatorsCancer vaccinesBy ApplicationLung cancerBreast cancerColorectal cancerOthersBy Geographical LandscapeNorth AmericaEuropeAsiaRest of World (ROW)This study identifies the adoption of various strategies for cancer immunotherapy market growth as one of the prime reasons driving the cancer immunotherapy market growth during the next few years. Also, emerging novel therapies for treating cancer and availability of advanced diagnostic modalities will lead to sizable demand in the market.\u003c\/p\u003e\n\n\u003cp\u003eThe report on the cancer immunotherapy market covers the following areas:Cancer immunotherapy market sizingCancer immunotherapy market forecastCancer immunotherapy market industry analysisThe robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cancer immunotherapy market vendors that include Amgen Inc., Amneal Pharmaceuticals Inc., AstraZeneca Plc, Bayer AG, Bristol Myers Squibb Co., Dendreon Pharmaceuticals LLC, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Gilead Sciences Inc., GlaxoSmithKline Plc, Immunocore Holdings Plc, Inovio Pharmaceuticals Inc., Johnson and Johnson, Merck KGaA, Novartis AG, Pfizer Inc., Sanofi, Seagen Inc., and Takeda Pharmaceutical Co. Ltd.. Also, the cancer immunotherapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.\u003c\/p\u003e\n\n\u003cp\u003eThe study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.\u003c\/p\u003e \n\n\u003cp\u003eThe publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"August, 2023 \/ 168 Pages \/ MCW16232067","offer_id":47647466029362,"sku":null,"price":3000.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-cancer-immunotherapy-market-2023-2027","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}